Skip to Content

Clinical Trials Search Results

Showing 1-1 of 1

Sorted By:

  • ACCRU RU011201I

    A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.

Showing trial 1 of 1

Also in this Section